Preparations of Rp-cyclic adenosine 3',5'-phosphorothioate (Rp-cAMPS) can contain biologically active amounts of adenosine

FEBS Lett. 1993 Mar 8;318(3):227-30. doi: 10.1016/0014-5793(93)80517-x.

Abstract

Superoxide anion (O2-.) production from human neutrophils stimulated by N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP, 1 microM) was inhibited by preparations of the inhibitor of cAMP-dependent protein kinase, Rp-cyclic adenosine 3',5'-phosphorothioate (Rp-cAMPS, 100 microM). This effect of Rp-cAMPS was reversed by xanthine amine congener (0.1 microM), an adenosine receptor antagonist, and by low concentrations of adenosine desaminase (0.02 mg/ml). HPLC analysis shows that these preparations of Rp-cAMPS contained concentrations of adenosine which could produce significant inhibition of fMLP-induced O2-. production. These results suggest that Rp-cAMPS should be used with caution in cells or tissues containing adenosine receptors, and that preparations of Rp-cAMPS should be treated with adenosine desaminase before use to avoid activation of adenosine receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / analysis*
  • Adenosine Deaminase / pharmacology
  • Chromatography, High Pressure Liquid
  • Cyclic AMP / analogs & derivatives*
  • Cyclic AMP / analysis
  • Cyclic AMP / pharmacology
  • Female
  • Humans
  • Male
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / drug effects
  • Neutrophils / metabolism
  • Protein Kinase Inhibitors
  • Superoxides / blood
  • Thionucleotides / analysis*
  • Thionucleotides / pharmacology

Substances

  • Protein Kinase Inhibitors
  • Thionucleotides
  • Superoxides
  • adenosine-3',5'-cyclic phosphorothioate
  • N-Formylmethionine Leucyl-Phenylalanine
  • Cyclic AMP
  • Adenosine Deaminase
  • Adenosine